|1.||Soliman, Karam F A: 6 articles (06/2010 - 01/2003)|
|2.||Bähr, Mathias: 4 articles (11/2012 - 07/2004)|
|3.||Lingor, Paul: 4 articles (11/2012 - 07/2004)|
|4.||Choi, Dong-Kug: 3 articles (01/2013 - 01/2011)|
|5.||Weishaupt, Jochen H: 3 articles (11/2012 - 05/2006)|
|6.||Soliman, K F A: 3 articles (10/2012 - 02/2003)|
|7.||Mazzio, E: 3 articles (10/2012 - 02/2003)|
|8.||Mazzio, Elizabeth A: 3 articles (06/2010 - 03/2004)|
|9.||Hillard, Cecilia J: 3 articles (10/2005 - 04/2003)|
|10.||Kalyanaraman, B: 3 articles (10/2005 - 04/2003)|
09/01/2010 - "In this study, the involvement of autophagy in the protection provided by hypoxic preconditioning against 1-methyl-4-phenylpyridinium (MPP(+))-induced neurotoxicity was studied in SH-SY5Y neuroblastoma cells. "
10/01/2012 - "Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine."
04/26/2011 - "Meyer) against 1-methyl-4-phenylpyridinium ion (MPP(+))-induced cytotoxicity in SH-SY5Y human neuroblastoma cells and explores the underlying mechanisms. "
02/01/2008 - "Cell-permeable Bcl-xL protected neuroblastoma cells from the selective neurotoxin 1-methyl-4-phenylpyridinium. "
02/14/2007 - "SAG protects human neuroblastoma SH-SY5Y cells against 1-methyl-4-phenylpyridinium ion (MPP+)-induced cytotoxicity via the downregulation of ROS generation and JNK signaling."
|2.||Parkinson Disease (Parkinson's Disease)
09/01/2012 - "The present study used the dopaminegic specific neurotoxin 1-methyl-4-phenylpyridinium (MPP(+) ) on neuron-like PC12 cells, which is a well-accepted model of Parkinson's disease. "
01/01/2011 - "In this study, we have investigated the effects of GE extracts and its major bioactive components on 1-methyl-4-phenylpyridinium (MPP+)-treated MN9D dopaminergic cells, a classic in vitro model for Parkinson's disease (PD). "
05/01/2010 - "The toxicity caused by cell exposure to 1-methyl-4-phenylpyridinium ion (MPP(+)) is a useful model in the study of Parkinson's disease (PD). "
06/01/1995 - "The possibility of functional difference of these cells in Parkinson's disease led us study the effect of 1-methyl-4-phenylpyridinium (MPP+) on them. "
01/01/2015 - "Neuroprotective effect of Buddleja cordata methanolic extract in the 1-methyl-4-phenylpyridinium Parkinson's disease rat model."
08/01/2012 - "In this study, we investigated the protective effects, and the possible mechanism of action, of SAL against 1-methyl-4-phenylpyridinium (MPP(+))-induced cell damage in rat adrenal pheochromocytoma PC12 cells. "
01/01/2011 - "To study the toxicity and its mechanisms of 1-methyl-4-phenylpyridinium ion (MPP+) on pheochromocytoma PC12 cells. "
08/12/2009 - "The aim of the present study is to explore the cytoprotection of H2S against 1-methyl-4-phenylpyridinium ion (MPP(+))-induced apoptosis and the molecular mechanisms underlying in PC12 cells, a rat cell line derived from pheochromocytoma cells. "
01/01/1997 - "Changes of energy metabolism induced by 1-methyl-4-phenylpyridinium (MPP+)-related compounds in rat pheochromocytoma PC12 cells."
04/15/1988 - "Inhibition of aromatic L-aminoacid decarboxylase in clonal pheochromocytoma PC12h cells by N-methyl-4-phenylpyridinium ion (MPP+)."
|4.||Parkinsonian Disorders (Parkinsonism)
07/01/2009 - "In this study we sought to determine whether H(C) also prevents the apoptosis induced by the mitochondrial poison 1-methyl-4-phenylpyridinium (MPP+), which induces a form of Parkinsonism. "
05/01/2013 - "1-Methyl-4-phenylpyridinium (MPP(+) ), a potent parkinsonizing agent in primates and rodents, is a blocker of mitochondrial complex I, therefore MPP(+) -induced parkinsonism is believed to depend largely on mitochondrial impairment. "
01/09/2009 - "1-methyl-4-phenylpyridinium ion (MPP(+)) has been shown to selectively inhibit mitochondrial function and induce a parkinsonism-like syndrome. "
01/01/2007 - "The neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) produces mitochondria-targeted injury, which contributes to parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine in mammals. "
05/01/2005 - "The molecular mechanism of 1-methyl-4-phenylpyridinium (MPP+), a Parkinsonism-inducing neurotoxin, has been studied in PC12 cells. "
11/01/1994 - "We have investigated the mode of death induced by complex I inhibition of dopaminergic cell cultures, and our results suggest that both 1-methyl-4-phenylpyridinium and rotenone cause apoptosis at low concentrations and necrosis at high concentrations. "
06/20/2008 - "In this study, we investigated the mechanisms underlying the neuroprotective effects of calbindin-D28K in staurosporine (STS)-induced apoptosis and 1-methyl-4-phenylpyridinium (MPP(+))-induced necrosis. "
|1.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
|3.||Oxidopamine (6 Hydroxydopamine)
|4.||Hydrogen Peroxide (Hydroperoxide)
|6.||Monoamine Oxidase (MAO)
|7.||Amyloid (Amyloid Fibrils)
|9.||Protein Kinases (Protein Kinase)